The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

CDMO giant Lonza unveiled plans to expand hard gelatin capsule production capacity at plants in India and China a week after announcing its intent to shed its capsules and health ingredients (CHI ...

The sprawling facility, which is bigger than 32 football fields, represents the largest of its kind in the country and is expected to crank out some 20 billion hard gelatin capsules per year ...

Hard Empty Capsule Market is Segmented by Type (Gelatin Capsule, Plant Capsule), by Application (Pharmaceutical, Healthcare Products): Global Opportunity Analysis and Industry Forecast ...

The following language describes the imported merchandise from Brazil, China, India and Vietnam: The merchandise subject to the scope of this investigation is hard empty capsules (HECs), which are ...

The global hard gelatin capsules market is projected to experience significant growth, with estimated sales valued at USD 1,940.3 million in 2024 and an anticipated increase to USD 3,409.7 million by ...

The global hard gelatin capsules market is poised for substantial growth, with a projected compound annual growth rate (CAGR) of 6.4% from 2022 to 2032. Recent studies indicate a strong demand for ...

Dei Biopharma’s new pharmaceutical and vaccine plant in Wakiso will commence commercial production of non-beta lactam tablets and Hard Gelatin capsules in October. This follows a recent approval ...

Hard-shelled capsules have two halves ... Gullapalli RP, Mazzitelli CL. Gelatin and non-gelatin capsule dosage forms. J Pharm Sci. 2017;106(6):1453-1465. doi:10.1016/j.xphs.